Molecules / Medroxyprogesterone / China

Medroxyprogesterone API manufacturers in China

CAS 71-58-9 Updated 9 July 2026
16
China-based manufacturers with an active filing of 16 worldwide
$5689.59
median export price per kg, all origins $4812.91 to $5947.26 · 7 exporters · 2025
Showing 8 of 16 China-based manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked China-based API manufacturers

01

Amphastar Nanjing Pharmaceuticals

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for medroxyprogesterone, filing since 2018. Its 2025 FDA inspection closed as NAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · NAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
02

Yangzhou Aurisco Pharmaceutical

China
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026

Registered with SFDA (Saudi Arabia) for medroxyprogesterone. Its GMP is recognised in 1 market.

US DMF
None on file
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
04

Taizhou Taifa Pharmaceuticals

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for medroxyprogesterone, filing since 2014.

US DMF
1 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
07

zhejiang xianju pharmaceutical

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for medroxyprogesterone, filing since 2006.

US DMF
1 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
08

Hubei Gedian humanwell Pharmaceutical

China
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for medroxyprogesterone, filing since 2014. Its 2025 FDA inspection closed as OAI, and its GMP is recognised in 2 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · OAI
GMP recognised in
2 markets
How this listing is sourced FDA, List of Drug Master Files
View profile

8 more manufacturers in China hold filings for medroxyprogesterone

The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.

Amphastar Nanjing PharmaceuticalsYangzhou Aurisco PharmaceuticalJiangsu Grand Xianle PharmaceuticalTaizhou Taifa PharmaceuticalsXian Guokang Ruijin PharmaceuticalZhejiang Xianju Yangguang Bioproductszhejiang xianju pharmaceuticalHubei Gedian humanwell Pharmaceutical
Open the full list with a free account

How this list is built

This page filters the worldwide Medroxyprogesterone manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.

Map medroxyprogesterone for your markets

Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.

Start for free
No sales call.

All Medroxyprogesterone manufacturers

Worldwide 16